Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib

Overview of attention for article published in Annals of Hematology, August 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,135 followers.

RT @Alahmari_MD: Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib | SpringerLink https://t.co/0HF…

RT @Alahmari_MD: Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib | SpringerLink https://t.co/0HF…

Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib | SpringerLink https://t.co/0HFtj00Op1

Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib | SpringerLink https://t.co/3jhAvQWXFz

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.